⌘K

Home/Filings/4/0001209191-22-013569

4//SEC Filing

Alland Leila 4

Accession 0001209191-22-013569

CIK 0001699382other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:25 PM ET

Size

5.3 KB

Accession

0001209191-22-013569

Insider Transaction Report

Form 4

Period: 2022-02-10

PMV Pharmaceuticals, Inc.PMVP

Chief Medical Officer

Transactions

Award
Employee Stock Option (right to buy)
2022-02-10+104,400→ 104,400 total
Exercise: $16.29Exp: 2032-02-10→ Common Stock (104,400 underlying)

Footnotes (1)

[F1]Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1

filerCIK 0001825216

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 4:25 PM ET
Size: 5.3 KB

View on SEC.gov